Skip Navigation
  • Text Size: A A A
  • Print
  • Email
  • Facebook
  • Tweet
  • Share
  • Print
  • Email
  • Facebook
  • Tweet
  • Share

NVAC Resolution: Adult Immunization – Adverse Events and Liability

Working Group on Adult Immunization

Recommendation #1 - May 1, 1997

WHEREAS, Adult Immunization, a report by NVAC, was issued in January, 1994, calling attention to the high cost in morbidity, mortality and health care dollars of vaccine-preventable diseases in adults in the United States; and

WHEREAS, in January 1994, the Assistant Secretary for Health requested the National Vaccine Program Office to consult with Federal agencies about implantation; and

WHEREAS, NVAC’s Working Group on Adult Immunization is overseeing a survey conducted by the National Vaccine Program Office to assess the degree to which the 5 goals, 18 recommendations and 72 strategies of Adult Immunization are being addressed by Federal agencies and thereby evaluate the current Federal effort; and

WHEREAS, the goals of the survey would be facilitated by reactivating the Interagency Committee on Immunization which in the past regularly enhanced access, information flow, and coordination between the National Vaccine Program Office and designated agency staff not only in regard to adult immunization, but also in regard to all immunization activities;

Then, be it therefore resolved that NVAC urges the Assistant Secretary for Health to give priority to carrying out a comprehensive study and analysis of existing data on adverse events and liability, and how these factors impact adult immunization, the purpose of such an analysis being to guide policy decisions regarding incorporation of adult vaccines within NVICP in a timely manner.

Recommendation #2 - May 1, 1997

WHEREAS, the cost in morbidity, mortality, and health care dollars of vaccine preventable disease in adults in the United States is substantial; and

WHEREAS, in the 1994 NVAC report, Adult Immunization, emphasis was placed on preserving and strengthening the capacity of the nation’s vaccine manufacturers to meet current and future needs for adult vaccines; and

WHEREAS, one strategy in the report to accomplish this recommendation is to explore the advantages and disadvantages of incorporating accepted vaccine-related adverse events which follow adult immunization into the National Vaccine Injury Compensation Program (NVICP); and

WHEREAS, various options for vaccine injury compensation are under consideration in the national plan for Influenza Pandemic Preparedness; and

WHEREAS, a comprehensive analysis of adverse events following administration of adult vaccines, has not been carried out,

Then be it therefore resolved:

The NVAC recommends that the Assistant Secretary for Health give priority to carrying out a comprehensive study and analysis of existing data on adverse events and liability, and how these factors impact adult immunization, the purpose of such an analysis being to guide policy decisions regarding incorporation of adult vaccines within NVICP in a timely manner.